Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the pathogen of coronavirus disease 2019 (COVID‐19), caused the outbreak escalated to pandemic. Reports suggested that near 1–3% of COVID‐19 cases have a fatal outcome. Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin rece...

Descrición completa

Detalles Bibliográficos

Principais autores:	Gábor Kriszta, Zsófia Kriszta, Szilárd Váncsa, Péter Jenő Hegyi, Levente Frim, Bálint Erőss, Péter Hegyi, Gábor Pethő, Erika Pintér
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Pharmacology
Assuntos:	SARS-CoV-2 angiotensin converrting enzyme angiotensin receptor blocker ACE2 animal study
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fphar.2021.619524/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!